BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28143896)

  • 1. Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations.
    Da Moura Semedo C; Webb M; Waller H; Khunti K; Davies M
    Postgrad Med J; 2017 May; 93(1099):289-294. PubMed ID: 28143896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease.
    Yamagishi S; Fukami K; Matsui T
    Int J Cardiol; 2015 Apr; 185():263-8. PubMed ID: 25814214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.
    Yasuda M; Shimura M; Kunikata H; Kanazawa H; Yasuda K; Tanaka Y; Konno H; Takahashi M; Kokubun T; Maruyama K; Sato N; Kakizaki M; Sato M; Tsuji I; Miyata T; Nakazawa T
    Curr Eye Res; 2015 Mar; 40(3):338-45. PubMed ID: 24871684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence advanced glycosylation end products as an independent predictor of mortality in high flux haemodialysis and haemodialysis patients.
    Nongnuch A; Davenport A
    Nephrology (Carlton); 2015 Nov; 20(11):862-7. PubMed ID: 26014842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease.
    Smit AJ; Gerrits EG
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):527-33. PubMed ID: 20844429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AGE Reader: A non-invasive method to assess long-term tissue damage.
    Atzeni IM; van de Zande SC; Westra J; Zwerver J; Smit AJ; Mulder DJ
    Methods; 2022 Jul; 203():533-541. PubMed ID: 33636313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products, measured as skin autofluorescence, at diagnosis in gestational diabetes mellitus compared with normal pregnancy.
    de Ranitz-Greven WL; Bos DC; Poucki WK; Visser GH; Beulens JW; Biesma DH; de Valk HW
    Diabetes Technol Ther; 2012 Jan; 14(1):43-9. PubMed ID: 21875328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
    Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
    Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence is a predictor of cardiovascular disease in chronic kidney disease patients.
    Furuya F; Shimura H; Takahashi K; Akiyama D; Motosugi A; Ikegishi Y; Haraguchi K; Kobayashi T
    Ther Apher Dial; 2015 Feb; 19(1):40-4. PubMed ID: 25545539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference values of skin autofluorescence as an estimation of tissue accumulation of advanced glycation end products in a general Slovak population.
    Simon Klenovics K; Kollárová R; Hodosy J; Celec P; Sebeková K
    Diabet Med; 2014 May; 31(5):581-5. PubMed ID: 24111899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
    Yue X; Hu H; Koetsier M; Graaff R; Han C
    Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
    de Vos LC; Mulder DJ; Smit AJ; Dullaart RP; Kleefstra N; Lijfering WM; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):933-8. PubMed ID: 24526694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic].
    Škrha J; Šoupal J; Prázný M; Škrha J
    Vnitr Lek; 2015 Apr; 61(4):346-50. PubMed ID: 25894266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Glycation Endproducts as Biomarkers for Risk of Diabetes and Cardiovascular Diseases by Skin Autofluorescence: A Noninvasive Optical Screening.
    Paolillo FR; Mattos VS; Borghi-Silva A; Bagnato VS; de Castro Neto JC
    Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):168-174. PubMed ID: 31050947
    [No Abstract]   [Full Text] [Related]  

  • 20. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.